Roche gave an update this week about GENERATION HD2, testing the HTT-lowering drug tominersen in people with HD. The trial is ...

A recent paper links CAG repeat expansion with widespread RNA changes, especially in brain cells vulnerable to HD. “Knocking ...

New research shines a light on an often-overlooked side of Huntington’s disease—psychosis. Understanding the impact of ...

New research suggests the adult brain can be convinced to grow new neurons to replace those lost in Huntington’s disease. The ...

In plain language. Written by scientists. For the global HD community.

Ed is a neurologist at the National Hospital for Neurology and Neurosurgery, London, UK, and a Professor of Neurology at University College London where he is Associate Director of the Huntington’s ...